NKp46+ innate lymphoid cells (ILC) modulate tissue homeostasis and anti-microbial immune responses. ILC development and function are regulated by cytokines such as Interleukin (IL)−7 and IL-15. However, the ILC-intrinsic pathways translating cytokine signals into developmental programs are largely unknown. Here we show that the anti-apoptotic molecule cellular FLICE-like inhibitory protein (c-FLIP) is crucial for the generation of IL-7/IL-15-dependent NKp46+ ILC1, including conventional natural killer (cNK) cells, and ILC3. Cytokine-induced phosphorylation of signal transducer and activator of transcription 5 (STAT5) precedes up-regulation of c-FLIP, which protects developing NKp46+ ILC from TNF-induced apoptosis. NKp46+ ILC-specific inactivation of c-FLIP leads to the loss of all IL-7/IL-15-dependent NKp46+ ILC, thereby inducing early-onset chronic colitis and subsequently microbial dysbiosis; meanwhile, the depletion of cNK, but not NKp46+ ILC1/3, aggravates experimental colitis. In summary, our data demonstrate a non-redundant function of c-FLIP for the generation of NKp46+ ILC, which protect T/B lymphocyte-sufficient mice from intestinal inflammation.
Innate lymphoid cells (ILC) modulate immune responses and tissue homeostasis at multiple levels. Reminiscent to the classification of helper T cell subsets, different types of ILC can be distinguished based on their cytokine and transcription factor expression profiles1. Type 1 NKp46+T-bet+ (ILC1) produce Interferon-γ (IFN-γ) and contribute e.g. to Toxoplasma gondii clearance2. Conventional NK cells (cNK) represent a subpopulation of ILC1, which is characterized by the co-expression of T-bet and Eomes1. Distinct from T-bet+Eomes− helper-like ILC1, cNK synthesize cytotoxic molecules, such as perforins and granzymes as well as death ligands (DLs) like tumor necrosis factor α (TNF), TNF-related apoptosis inducing ligand (TRAIL) and FAS ligand (FASL) enabling them to induce target cell apoptosis3. On the contrary, NKp46−GATA3+ ILC2 produce Interleukin (IL)−5 and IL-13 and promote helminth rejection4, while NKp46+/−RORγt+ ILC3 support anti-bacterial responses in mice lacking T and B lymphocytes5. Furthermore, ILC3 regulate tissue homeostasis and regeneration, e.g., in the intestine and lung6. For example, ILC3-derived IL-22 promotes intestinal epithelial stem cell regeneration7, providing an explanation for the tissue-protective effect of IL-22 in the course of dextran sodium sulfate (DSS)-induced colitis8.
Most studies defining immune modulatory and tissue protective functions of NKp46+ ILC3 were performed with T and B lymphocyte (T/B)-deficient mice. However, recent evidence suggests that T lymphocytes can compensate for the lack of NKp46+ ILC39,10,11. Whether the degree of compensation is determined by the experimental system or whether ILC3 are generally of limited importance in a T/B-competent host is still unclear.
Developing and mature ILC express a multitude of cytokine receptors including those for IL-15 and IL-712. Both cytokines signal via signal transducer and activator of transcription 5 (STAT5)13 and are crucial for ILC development and survival2,14. For example, IL-15 withdrawal activates the intrinsic apoptosis pathway in cNK15. This is associated with the failure to repress expression of the pro-apoptotic molecule Bcl2-interacting mediator of cell death (Bim), the loss of anti-apoptotic myeloid cell leukemia-1 (Mcl-1) and the subsequent death of cNK15. IL-7 and IL-15 are produced by e.g., stromal fibroblasts16,17 and intestinal epithelial cells (IEC)6,18, which create the cytokine environment required for the maintenance of ILC homeostasis and function12. However, ILC-intrinsic signaling molecules required for the conversion of environmental cues into developmental programs are largely unknown. In order to identify such signaling molecules and to define unique functions of intestinal NKp46+ ILC, we made use of NKp46iCre mice19. These mice are T/B-competent and allow targeted gene inactivation in NKp46+ ILC.
Here, we show that the anti-apoptotic molecule cellular FLICE-like inhibitory protein (c-FLIP), a master regulator of the extrinsic apoptosis pathway20, is a target of STAT5-dependent cytokine signaling in NKp46+ ILC. The NKp46-specific inactivation of c-FLIP leads to the loss of NKp46+ ILC1, including cNK, and ILC3 without affecting T and B lymphocyte homeostasis. Furthermore, we provide evidence that cytokine-dependent c-FLIP induction prevents a TNF-induced suicide program in developing NKp46+ ILC. Finally, we define a non-redundant function of c-FLIP-dependent NKp46+ cNK in the intestine. Specifically, different from mice only lacking NKp46+ ILC3, mice lacking NKp46+ cNK fail to recover from acute colitis and develop early signs of chronic disease. Furthermore, although not affecting the establishment of a normal commensal microbiota in the steady state, NKp46+ ILC counteract inflammation-associated commensal dysbiosis. In summary, we show that the anti-apoptotic molecule c-FLIP is crucial for the cytokine-dependent development of NKp46+ cNK/ILC1 and ILC3 and subsequent protection from intestinal inflammation by cNK, a function that cannot be compensated by other immune cells.
c-FLIP is essential for the development of NKp46+ ILC
c-FLIP is a master regulator of the extrinsic apoptosis pathway20 and protects immune and non-immune cells from caspase 8-dependent apoptosis21,22. The expression of c-FLIP is crucial for T cell development23 and is up-regulated by activated human and mouse T cells24. IL-15 is crucial for the development of T-bet+ ILC1 including cNK25,26. Whether and how the external apoptosis pathway is involved in IL-15-dependent ILC development and function was unclear. In order to identify a functional link between IL-15 signaling and Cflar (encoding c-FLIP) gene regulation, CD3−NK1.1+NKp46+ ILC were purified from spleens of C57BL/6 (B6) mice and cultured for 16 h in the presence or absence of IL-15. The murine Cflar gene encodes for two isoforms of c-FLIP, the long form c-FLIPL and the short Raji isoform c-FLIPR27. Quantitative real-time PCR (RT-qPCR) revealed that NKp46+ ILC significantly up-regulate the mRNA of the long isoform c-FLIPL, but not c-FLIPR, in response to IL-15 (Fig. 1a). Elevated Cflar gene activity correlated with the phosphorylation of STAT5 and elevated c-FLIP protein levels (Fig. 1b). The blockade of STAT5 phosphorylation by pimozide led to impaired IL-15-dependent c-FLIP up-regulation (Fig. 1b). Hence, c-FLIP is a target of STAT5-dependent IL-15 signaling in mature NKp46+ ILC.
Next, we investigated whether c-FLIP is required for the development of IL-15/STAT5-dependent NKp46+ ILC. For this purpose, conditional STAT5 (STAT5fl/fl) and c-FLIP (c-FLIPfl/fl) knockout mice were crossed to NKp46iCre-transgenic mice to generate NKΔSTAT5 and NKΔc-FLIP mice, respectively. NKp46iCre-transgenic mice harboring wildtype alleles of the respective target gene served as NKWT controls. Similar to IL-15-deficient (IL-15−/−) and IL-15 receptor α-deficient (IL-15R−/−) mice, numbers of splenic NKp46+ ILC were strongly reduced in NKΔSTAT5 and NKΔc-FLIP mice (Fig. 1c). IL-15 deprivation causes cNK apoptosis28. Accordingly, residual splenic IL-15−/− and IL-15R−/− NKp46+ ILC showed increased rates of caspase-3/7 activity (Fig. 1d). The frequencies of NKp46+ ILC expressing active caspase-3/7 were also elevated in NKΔSTAT5 and NKΔc-FLIP mice (Fig. 1d).
Furthermore, we observed increased frequencies of immature double negative (DN) NK1.1−NKp46− and single positive (SP) NK1.1+NKp46− cells in conjunction with a reduced abundance of double positive (DP) NK1.1+NKp46+ ILC in spleens and bone marrow (BM) of IL-15−/−, IL-15R−/−, NKΔSTAT5, and NKΔc-FLIP mice (Fig. 1e, f). Of note, the development of other immune cells remained unaltered in NKΔc-FLIP mice (Supplementary Fig. 1). Altogether, our results demonstrate that c-FLIP is crucial for the IL-15/STAT5-dependent development of NKp46+ ILC in the BM and their survival in the periphery.
c-FLIP protects ILC precursors from TNF-induced apoptosis
ILC1 produce effector molecules such as IFN-γ and DLs like TNF and TRAIL29. In the absence of c-FLIP, human cNK become sensitive to their own effector molecules and undergo apoptosis30. We therefore hypothesized that the loss of NKp46+ ILC in NKΔc-FLIP mice resulted from death receptor (DR)-induced apoptosis during ILC1 development. To elucidate whether effector genes are activated in BM ILC, we first analyzed IFN-γ reporter mice expressing eYFP under control of the Ifng promoter. As shown in Fig. 2a, Ifng promoter activity increased from the NK1.1−NKp46− DN to the NK1.1+NKp46− SP stage and reached its maximum at the NK1.1+NKp46+ DP stage. Similarly, TNF mRNA levels increased progressively from the DN to the DP stage (Fig. 2b). Of note, DR mRNAs for TRAIL-R2, FAS and TNF-RI were also detectable throughout ILC development, the latter being particularly high in DP cells (Fig. 2c). In addition, c-FLIPL and c-FLIPR mRNAs were expressed at all developmental stages (Fig. 2d). Interestingly, only c-FLIPL mRNA showed a maturation-associated increase (Fig. 2d) similar to TNF (Fig. 2b), TRAIL-R2 and TNF-RI (Fig. 2c).
In order to elucidate the impact of DLs on c-FLIP-dependent ILC development, we established an in vitro culture system. DN cells were enriched from BM of NKWT and NKΔc-FLIP mice and cultured for 9 days. In accordance with our in vivo data, the generation of DP cells was impaired in the absence of c-FLIP (Fig. 2e). Importantly, this effect could be recovered most effectively by the antibody-mediated blockade of TNF (Fig. 2f).
Together, our results demonstrate that TNF and TNF-RI up-regulation are programmed events in the course of NKp46+ ILC development. The partial recovery of NKΔc-FLIP ILC development by αTNF treatment strongly suggests that the cytokine-induced, STAT5-dependent up-regulation of c-FLIPL (Fig. 1a, b) is crucial for protection of developing ILC from TNF-induced apoptosis.
IL-7- and IL-15-dependent intestinal NKp46+ ILC require c-FLIP
The small intestine (SI) harbors NKp46+T-bet+ ILC1, including T-bet+Eomes+ cNK, as well as NKp46−GATA3+ ILC2 and NKp46+/−CD4+/−RORγt+ ILC312. In order to analyze whether c-FLIP affects intestinal ILC homeostasis, leukocytes were isolated from the small intestinal lamina propria of NKWT and NKΔc-FLIP mice. The abundance of NKp46+NK1.1+ ILC (Fig. 3a, e) including T-bet+ ILC1 (Fig. 3b, e), NK1.1+Eomes+ cNK (Fig. 3c, e) and NKp46+RORγt+ ILC3 (Fig. 3d, e) were strongly reduced in the SI of NKΔc-FLIP mice. Importantly, numbers of NKp46−CD4+/−RORγt+ ILC3 (Fig. 3d, f) and NKp46−GATA3+ ILC2 (Fig. 3f) remained unaltered in NKΔc-FLIP mice. Hence, NKΔc-FLIP mice lack NKp46+ ILC but have normal numbers of NKp46− ILC in the SI. Similar data were obtained with NKΔSTAT5 mice (Fig. 3g, h) further emphasizing the functional link between STAT5 and c-FLIP.
The development of cNK/ILC1 largely relies on IL-152,25,31 (Supplementary Fig. 2) rather than IL-7 signaling. The latter point is exemplified by the fact that cNK numbers in spleen and SI did not differ significantly between RAG1−/− and RAG1−/− × IL-7R−/− mice (Fig. 3i, j). On the contrary, numbers of all other SI NKp46+ and NKp46− ILC subsets were strongly reduced in RAG1−/− × IL-7R−/− mice (Fig. 3j, k). IL-15 can partially compensate for the lack of IL-7R signaling32 providing an explanation for the survival of some residual ILC in RAG1−/− × IL-7R−/− mice (Fig. 3j, k). Of note, this compensatory effect was less efficient for NKp46+RORγt+ ILC3, which were more severely affected by the lack of IL-7R signaling than NKp46−RORγt+ ILC3 (Fig. 3l; lower panel).
IL-7R and IL-15R signaling converge at the level of STAT5 phosphorylation which precedes c-FLIP up-regulation (Fig. 1b). Hence, the simultaneous lack of IL-15- and IL-7-dependent NKp46+ ILC1 and ILC3 in NKΔc-FLIP and NKΔSTAT5 mice strongly suggests that both cytokines promote ILC development and survival via the STAT5-dependent induction of c-FLIP.
c-FLIP-dependent NKp46+ ILC protect mice from acute colitis
Inflammatory bowel disease (IBD) is associated with pronounced changes in ILC1 and ILC3 frequencies and functions29. Whether and how the absence of NKp46+ ILC1 and ILC3 affects the course of IBD was unclear. In order to address this subject, NKΔc-FLIP and control mice were treated with DSS for 5 days. The administration of DSS causes IEC damage, loss of epithelial integrity, innate immune cell activation, and results in IBD-like symptoms33. To monitor disease progression, relative body weight (Fig. 4a), feces consistency (Fig. 4b), and the degree of intestinal bleeding (Fig. 4c) were determined and the overall colitis score was calculated (Fig. 4d). As shown in Fig. 4a–d, disease severity was strongly increased in NKΔc-FLIP mice. Accordingly, the specific colon weight was strongly increased in NKΔc-FLIP mice indicating edema formation and increased cellularity (Fig. 4e). Furthermore, the colon length was significantly decreased in NKΔc-FLIP mice (Fig. 4f, g) and inflammation-related alterations in tissue architecture were more pronounced (Fig. 4h). When colonic immune cell infiltrates were analyzed, we observed the almost complete absence of NKp46+NK1.1+ ILC including T-bet+ ILC1, Eomes+ cNK and RORγt+ ILC3 (Fig. 4i, j) in NKΔc-FLIP mice. On the contrary, numbers of NKp46− ILC did not differ significantly between NKΔc-FLIP and NKWT mice (Fig. 4k). Importantly, CD45+CD11b+ granulocytes, in particular pro-inflammatory Ly6C+Ly6G+ neutrophils, rather than Ly6C−Ly6G+/− monocytes, accumulated more efficiently in the inflamed colon of NKΔc-FLIP mice (Fig. 4l, m). Thus, the lack of c-FLIP-dependent, NKp46+ ILC promotes acute colitis and cannot be compensated by T or B lymphocytes.
NKp46+ ILC protect mice from early onset of chronic colitis
Repeated DSS administration causes chronic colitis33. Since it was unclear whether this is also affected by NKp46+ ILC, NKWT and NKΔc-FLIP mice were treated repetitively with DSS. In agreement with the results from the acute colitis model (Fig. 4a–d), disease severity was significantly more pronounced in NKΔc-FLIP than in NKWT mice after the first 5-day period of DSS treatment (Fig. 5a). After termination of the first DSS treatment, NKWT mice had recovered completely until day 15. This was not the case for NKΔc-FLIP mice. They failed to recover completely until day 19, when the second 5-day period of DSS administration was initiated (Fig. 5a). Importantly, NKΔc-FLIP mice rapidly developed maximum disease scores comparable to those following the first phase of DSS treatment (Fig. 5a). NKWT mice showed elevated disease scores at day 25, which were above those observed at the peak of the first treatment cycle but still significantly below those of NKΔc-FLIP mice (Fig. 5a).
Following the second DSS cycle, NKWT mice did not recover completely demonstrating the establishment of chronic colitis. Still, recovery was significantly less efficient in NKΔc-FLIP mice (Fig. 5a). After an additional phase of DSS treatment, disease scores in NKWT mice were slightly above those observed in the previous phase but still below those in NKΔc-FLIP mice (Fig. 5a). Analysis of colon samples at day 42 revealed a significant decrease in colon length (Fig. 5b) and an increase in specific colon weight in NKΔc-FLIP mice (Fig. 5c). Furthermore, inflammation-related histopathological changes were more pronounced in the colon of NKΔc-FLIP mice (Fig. 5d–f) correlating well with their increased disease severity (Fig. 5a).
The cytokine milieu has a major impact on the course of IBD34. We therefore determined cytokine production in supernatants of cultured colon samples isolated at days 3 and 10 after the initiation of DSS treatment. Except reduced levels of IFN-γ and GM-CSF in NKΔc-FLIP mice, levels of IL-22, IL-10, IL-12p70, TNF, IL-17A, IFN-β, IL-6 and MCP-1 did not differ significantly between mouse strains at day 3 (Fig. 5g; upper row). At day 10, IL-12p70, MCP-1, and GM-CSF levels were significantly lower in NKΔc-FLIP supernatants. On the contrary, all other cytokines were produced at comparable amounts (Fig. 5g; lower row). It is important to stress out that GM-CSF was the only cytokine that was reduced in NKΔc-FLIP samples at both time points. Given that the relative importance of a particular cytokine correlates positively with the persistence of its production35, we hypothesized that GM-CSF is of particular importance for disease control in our model. In order to test whether the number of GM-CSF-producing ILC is altered in the inflamed colon of NKΔc-FLIP mice, colonic lamina propria leukocytes (LPL) were analyzed by flow cytometry at day 5 of DSS treatment. As shown in Fig. 5h, numbers of GM-CSF+NKp46+, but not NKp46−, ILC were significantly reduced in NKΔc-FLIP mice. GM-CSF promotes epithelial cell recovery after DSS treatment and GM-CSF deficiency is associated with disease aggravation36. Hence, increased disease severity and impaired regeneration in NKΔc-FLIP mice (Fig. 5a–f) correlated with (i) the reduced production of GM-CSF in colon samples and (ii) lower numbers of GM-CSF+NKp46+ ILC in the colon of NKΔc-FLIP mice (Fig. 5g, h). In summary, our data (Fig. 5a–h) provide evidence for a function of c-FLIP-dependent NKp46+ ILC1/3 in T/B-sufficient mice. These cells are crucial to limit intestinal inflammation, facilitate recovery and thereby prevent the early onset of chronic intestinal inflammation.
NKp46+ ILC counter inflammation-related commensal dysbiosis
Intestinal homeostasis is maintained by a multitude of interactions between immune cells, IEC and the commensal microbiota6. Disruption of this complex network is frequently associated with aberrant immune responses, subsequent inflammation and microbial dysbiosis37,38. Particularly, we have shown that the severity of DSS colitis is influenced by specific interactions between microbial communities and host immune pathways with distinct changes in microbiota composition being sufficient for exacerbation of the disease39. We therefore asked next whether the presence or absence of NKp46+ ILC affects the relative abundance of pro- and/or anti-inflammatory bacteria in NKWT and NKΔc-FLIP mice. For this purpose, feces samples were collected before induction of chronic DSS colitis (before DSS) and at the end of the observation period (after DSS). To minimize potential cage-specific variations in microbiota composition, NKWT and NKΔc-FLIP mice littermates were, whenever possible, co-housed permanently. Feces samples were analyzed using 16S rRNA gene sequencing of the V4 region40 and microbiota composition was compared between NKWT and NKΔc-FLIP mice (Fig. 6a–c). Our analyses revealed a complex pattern of community structures in NKWT and NKΔc-FLIP mice. The relative contribution of factors including “Genotype”, “Cage”, and “Time point” to variability within the microbiota demonstrated time point-dependent differences between both mouse lines (Fig. 6a; R2 = 0.214, p < 0.001) indicating that repeated colitis induction had a lasting impact on the microbiome composition. Notably, genotype-dependent differences in microbiome composition were not visible before induction of DSS colitis (Fig. 6a, b; ADONIS values). Thus, NKp46+ ILC do not have a major impact on the composition of the commensal microbiota under steady-state conditions. Under inflammatory conditions, however, the presence or absence of NKp46+ ILC in NKWT or NKΔc-FLIP mice, respectively, is associated with genotype-specific changes in the microbiota (Fig. 6c; R2 = 0.123, p < 0.01).
Additionally, we compared the bacterial taxa in the commensal microbiota of NKWT and NKΔc-FLIP mice. In line with Fig. 6a–c, the composition of the commensal microbiota was very similar prior to the induction of colitis (Fig. 6d). In contrast, chronic DSS colitis induced overt changes in microbiome composition in both mouse strains and distinct changes between them (Fig. 6e).
We used the linear discriminant analysis (LDA) effect size (LEfSe) method considering only operational taxonomic units (OTUs) with the Kruskal–Wallis test < 0.05 and LDA scores > 3.0 to identify statistically significant differences41 between diseased NKWT and NKΔc-FLIP mice (Fig. 6f). In NKWT mice the genera Prevotella (OTU 8), Muribaculum (OTU 5; within the Bacteriodales S24-7), Alistipes (OTU 33; within the family Rikenellaceae) and two undefined OTUs (OTU 94 and OTU 76; within the family Ruminococcaceae) relatively expanded in the course of DSS colitis (Fig. 6f). In feces of NKΔc-FLIP mice the frequencies of bacteria belonging to the genera Turicimonas (OTU 75; within the Alcaligenaceae), Turicibacter (OTU 2; within the Erysipelotrichaceae), Bacteroides (OTU 12; within Bacteroidaceae) and a bacterium belonging to an ambiguous taxon (OTU 61; within the Coriobacteriaceae) were significantly increased. Elevated levels of Turicibacter and Bacteroides correlate positively with inflammation and tumor development in mice42. Moreover, expansion of Alcaligenaceae is frequently observed in Crohn’s disease patients and drives systemic inflammation in mice43. Hence, the lack of NKp46+ ILC in NKΔc-FLIP mice is associated with increased disease severity (Fig. 5a–f), altered cytokine expression (Fig. 5g, h) and the subsequent expansion of potentially pathogenic bacteria (Fig. 6a–f).
IL-7R-dependent NKp46+ ILC3 do not affect acute colitis
In DSS-treated mice, NKp46+ ILC3 are an important source of tissue-protective IL-22 and their deletion in T/B-deficient RAG−/− mice is associated with increased disease severity8. We therefore hypothesized that the lack of NKp46+ ILC3 was responsible for disease aggravation in NKΔc-FLIP mice (Figs. 4a-h and 5a-f). In order to eliminate NKp46+ ILC3 from T/B-competent mice, we exploited the strict IL-7R-dependence of NKp46+RORγt+ ILC3 (Fig. 3l). For this purpose, conditional IL-7R (IL-7Rfl/fl) knockout mice were crossed to NKp46iCre-transgenic mice to generate NKΔIL-7R mice. As compared to NKWT mice, SI-derived helper-like NKp46+CD90+ ILC from NKΔIL-7R mice hardly expressed any IL-7Rα (CD127) while non-targeted NKp46−CD90+ ILC still expressed it at normal levels. As expected, NKp46+CD90− cNK expressed least IL-7R in both mouse strains32 (Fig. 7a). Next, we determined the composition of the ILC pool in the SI of NKWT and NKΔIL-7R mice. NKΔIL-7R mice were nearly completely devoid of NKp46+RORγt+ ILC3 (Fig. 7b, c), while numbers of NKp46+Tbet+ ILC1 (Fig. 7c), NKp46+Eomes+ cNK (Fig. 7b, c), and all NKp46− ILC subsets (Fig. 7c) appeared normal compared to NKWT mice.
Next, we tested whether the lack of NKp46+RORγt+ ILC3 affects the outcome of acute DSS colitis. For this purpose, NKWT and NKΔIL-7R mice were treated with DSS for 5 days and disease parameters were determined. As shown in Fig. 7d, relative body weight did not differ between both mouse strains. Altogether, our results demonstrate that the lack of NKp46+RORγt+ ILC3 does not affect the course of DSS-induced colitis.
cNK cells ameliorate acute intestinal inflammation
Since NKp46+ ILC3 did not affect the course of DSS-induced colitis (Fig. 7d), we hypothesized that NKp46+ ILC1 deficiency accounted for disease aggravation in NKΔc-FLIP mice (Figs. 4a–h and 5a–f). This assumption was supported by the fact that the mild course of disease in NKWT mice correlated with the accumulation of c-FLIP-dependent Ly49C+ cNK (Supplementary Fig. 3). In order to elucidate whether cNK are involved in disease modulation, B6 mice were treated with cNK-depleting anti-Asialo-GM1 (αAsialo) or control antibody. As shown in Supplementary Fig. 4A, αAsialo-treated mice suffered more from DSS-induced colitis than control animals. Since the efficacy of cNK depletion may vary between target tissues, we analyzed the frequencies and absolute numbers of colonic ILC. Anti-Asialo-treated mice contained significantly fewer NKp46+NK1.1+ ILC in the inflamed colon (Supplementary Fig. 4B, F, I). This reduction was mainly due to the depletion of NKp46+NK1.1+Eomes+ cNK (Supplementary Fig. 4C, G, J) and correlated with elevated frequencies of neutrophils in peripheral blood (Supplementary Fig. 4E), similar to what we had observed in the inflamed colon of NKΔc-FLIP mice (Fig. 4l and m). On the contrary, frequencies of NKp46+Eomes− ILC1 (Supplementary Fig. 4C) and NKp46+/−RORγt+ ILC3 (Supplementary Fig. 4D, H) remained largely unaffected by αAsialo treatment, whereas absolute numbers of the latter were significantly reduced (Supplementary Fig. 4K). Hence, antibody-mediated side effects on other ILC subsets could not be formally excluded.
As a result of NKp46-specific Eomes inactivation, cNK development is strongly impaired while other ILC remain largely unaffected44,45,46. We therefore generated cNK-deficient NKΔEomes (NKp46iCre × Eomesfl/fl) mice to further validate the anti-inflammatory function of cNK. NKΔEomes mice and control animals were treated with DSS for 5 days. Similar to NKΔc-FLIP (Fig. 4a–d) and αAsialo-treated B6 mice (Supplementary Fig. 4A), disease severity was significantly increased in NKΔEomes mice as compared to NKWT controls (Fig. 8a–d). In accordance with a more pronounced inflammatory response, colon weight of NKΔEomes mice was increased (Fig. 8e) while its length was decreased (Fig. 8f, g). Importantly, we confirmed the selective loss of Eomes+ cNK, but not helper-like ILC1, in the inflamed colon of NKΔEomes mice (Fig. 8h, i). This correlated with the accumulation of neutrophils (Fig. 8j, k) similar to what we had observed for NKΔc-FLIP mice (Fig. 4l, m). Thus, cNK depletion, either by αAsialo treatment (Supplementary Fig. 4) or NKp46-specific Eomes inactivation (Fig. 8), is sufficient to aggravate disease. Hence, our results strongly suggest that cNK act as immune modulators in the inflamed colon with anti-inflammatory properties superior to all other NKp46+ ILC.
Immune cells are equipped with a multitude of cytokine receptors allowing them to sense changes in their environment and adapt activation as well as survival thresholds accordingly13,47. How cytokine signals are translated into ILC-specific developmental/survival programs is largely unknown. IL-15 is an environmental factor that is indispensable for ILC1/cNK development25,26. Previous studies demonstrated that IL-15 withdrawal impairs cNK metabolism48 and activates the intrinsic apoptosis pathway15. In the absence of IL-15 cNK fail to downregulate the pro-apoptotic molecule Bim. At the same time, the induction of the anti-apoptotic Mcl-1 is impaired and IL-15-deprived cNK undergo apoptosis15.
Here, we provide evidence for an additional mode of ILC-specific, non-redundant IL-15 action. We identify c-FLIP as a target of STAT5-dependent IL-15 signaling. c-FLIP is a master regulator of the extrinsic apoptosis pathway20 and protects immune and non-immune cells from caspase 8-dependent apoptosis21,22. Usually, this type of apoptosis is triggered by DLs such as TNF or TRAIL, which are produced at high levels by mature ILC129. To prevent their DL-induced premature death in the course of an immune response c-FLIP is required30. Our results demonstrate that immature ILC already require c-FLIP in the very early phase of their development. This appears to be due to the fact that developing ILC up-regulate effector genes such as Ifng and Tnf already at the SP stage. This is paralleled by DR up-regulation, particularly of TNF-R1, thus rendering BM ILC sensitive to TNF-induced apoptosis. Consequently, only c-FLIP-competent ILC precursors developed into DP ILC in vitro. Importantly, the blockade of TNF partially restored the generation of c-FLIP-deficient DP ILC. Whether TNF production by developing ILC is a cell autonomous process or whether it is influenced by environmental factors remains to be shown.
T/B-deficient mice lacking NKp46+ ILC3 succumb to C. rodentium infection. On the contrary, their T/B-competent counterparts control infection9,10. This demonstrates that adaptive immune cells and NKp46+ ILC have redundant functions9,10, a conclusion that is supported by human data11. However, NKp46+ ILC3 are indispensable for the maintenance of cecal homeostasis9. Hence, the relative contribution of NKp46+ ILC to the modulation of immune responses appears to vary in a context-dependent fashion. This is further exemplified by apparently opposing results obtained in mouse models of intestinal inflammation. While NKp46+ ILC3 protect T/B-deficient mice from DSS-induced colitis8, they promote αCD40-induced colitis in T-deficient mice10. Whether and how NKp46+ ILC affect the severity of DSS-induced colitis in T/B-competent mice had not been studied in detail before. To address this issue, we used ILC1/3-deficient, T/B-competent NKΔc-FLIP mice. Our data clearly demonstrate that NKp46+ ILC are indispensable for disease control. Neither T or B lymphocytes nor NKp46− ILC were able to compensate for the lack of NKp46+ ILC in NKΔc-FLIP mice. Importantly, with the help of NKΔIL-7R mice, we could exclude NKp46+ ILC3 as major regulators of acute DSS-induced colitis emphasizing the importance of NKp46+ ILC1. In DSS-treated NKΔc-FLIP mice, ILC-deficiency correlated with increased disease scores, altered cytokine profiles and the accumulation of neutrophils in the inflamed colon. Our data suggest that this neutrophil-associated effect was due to the lack of cNK, which can limit the recruitment and pro-inflammatory function of neutrophils49. This anti-inflammatory function of cNK is NKG2A-dependent as shown by the fact that anti-NKG2A antibodies block cNK–neutrophil interactions in vitro and exacerbate DSS-induced colitis in vivo. Based on these observations, a dominant regulatory role of cNK in DSS-induced colitis was postulated49. However, NKG2A is not only expressed by cNK but also by, e.g. ILC126 and CD8+ T cells50. Hence disease exacerbation in response to anti-NKG2A treatment49 may involve multiple NKG2A+ immune cell types. However, as we have shown here, (i) the mild course of disease in NKWT mice correlated with the accumulation c-FLIP-dependent Ly49C+ cNK, (ii) αAsialo-GM-mediated cNK depletion aggravated disease in B6 mice and, above of all, cNK-deficient NKΔEomes mice were by far more sensitive to DSS-induced colitis as compared to controls. Of note, disease aggravation was comparable for cNK-deficient NKΔEomes and NKΔc-FLIP mice lacking all NKp46+ ILC. Hence, our findings support the view that cNK have a dominant anti-inflammatory function in DSS-induced colitis, which results, at least partially, from the restriction of neutrophil infiltration and function in the inflamed colon51. However, it is important to emphasize that the cell surface molecules used to define neutrophils in our experimental system are used to define myeloid-derived suppressor cells (MDSCs) in others52. In addition to their nearly identical cell surface phenotype, MDSCs and neutrophils share functional features as well. For example, and contrary to their well-known anti-inflammatory functions in tumor models53, MDSCs were shown to promote DSS-induced colitis54 similar to neutrophils49. Hence, our experimental approach does not allow us to define the relative contribution(s) of MDSCs and neutrophils to disease progression. Based on the complex intercellular interactions driving colitis55 we also cannot exclude that cNK deficiency promotes pro-inflammatory functions of other cell types.
NKΔc-FLIP mice developed maximum disease scores after only a single phase of DSS administration. Furthermore, they failed to recover completely after the first DSS cycle and showed maximum disease scores after each additional DSS phase. This early establishment of chronic disease in NKΔc-FLIP mice correlated with the prolonged reduction of tissue-protective GM-CSF and lower numbers of GM-CSF+NKp46+ ILC including cNK. Hence, the protective effect of cNK may not only rely on the suppression of neutrophil effector functions but also on the production of tissue-protective GM-CSF. It is important to stress that no other immune cell type, including NKp46+ ILC1/3, is able to compensate for the early protective and regenerative effects of NKp46+ cNK. This may, at least partially, rely on the disease-related control of the commensal microbiota. Of note, the lack of NKp46+ ILC in NKΔc-FLIP mice did not have a significant impact on the composition of the commensal microbiota prior to DSS-induced colitis. This argues against a direct impact of NKp46+ ILC on the establishment of the microbiota under homeostatic conditions in T/B-competent mice. Nevertheless, after establishment of chronic colitis the composition of the commensal microbiota changed in a NKp46+ ILC-dependent fashion. For example, Coriobacteriaceae, Alcalignaceae, Erysipelotrichaceae, and Bacteroidaceae were more abundant in NKΔc-FLIP mice, while Rikenellaceae, Bacteriodales S24-7, Prevotellaceae, and Ruminococcaceae were enriched in NKWT mice. Commensal dysbiosis is frequently observed in different disease models and the altered abundance of certain bacteria has disease-modulating effects37,38. For example, the overabundance of Bacteroides has been associated with increased rates of inflammation and tumor development42. Moreover, the expansion of bacteria from the family Alcaligenaceae drives inflammation in ILC-depleted RAG1−/− mice43. On the contrary, the enhanced relative abundance of Prevotella in diseased NKWT mice may have beneficial effects, since it correlates inversely with inflammation in a mouse model of inflammation-induced carcinogenesis42. Altogether, these results demonstrate that the expansion of disease-promoting microbes, such as Proteobacteria, i.e. Alcaligenaceae, occurs selectively in DSS-treated NKΔc-FLIP mice. This indicates that c-FLIP-dependent NKp46+ ILC modulate the composition of the commensal microbiota under inflammatory conditions but not prior to disease. Whether alterations of the commensal microflora are a cause or a result of inflammation remains an important question for the future.
In summary, we identify the anti-apoptotic molecule c-FLIP as a target of cytokine-induced STAT5 activation, which is indispensable for the development of IL-15- and IL-7-dependent NKp46+ ILC1 and ILC3, respectively. Furthermore, we provide evidence that cNK, but not ILC1/3, restrict the degree of intestinal inflammation correlating with specific alterations in the commensal microbiota. Hence, c-FLIP-dependent NKp46+ cNK protect T/B-sufficient mice from intestinal inflammation, a function that cannot be replaced by any other immune cell.
NKp46iCre 19, c-FLIPfl/fl 23, STAT5fl/fl 56 (provided by L. Hennighausen), IL-15−/− 25, IFN-γ reporter mice (Great)57, RAG1−/−58, IL-7R−/−59, and RAG1−/− × IL-7R−/− were maintained under specific pathogen-free conditions at the central animal facility of the Medical Faculty of the Otto-von-Guericke-University Magdeburg. IL-7Rfl/fl (stock no. 022143)60, Eomesfl/fl (stock no. 017293)61, and IL-15Rα−/− mice (stock no. 003723)31 including appropriate control mice were purchased from The Jackson Laboratory. Whenever possible, control littermates were used and cohoused (age 8–16 weeks). Both sexes were considered equally. Experimental procedures were approved by the relevant animal experimentation committee and performed in compliance with international and local animal welfare legislations (Landesverwaltungsamt Sachsen-Anhalt, permit numbers AZ 42502-2-1202 and AZ 42502-2-1521 Uni MD).
Mice were used euthanized by isoflurane inhalation overdose. Single-cell suspensions of spleen were prepared by forcing the organs through metal sieves. BM leukocytes were flushed from tibia, femur, and coxal bone using PBS/2 mM EDTA (ROTH). To lyse erythrocytes, cell suspensions were incubated with ACK lysis buffer for 90 s and subsequent addition of RPMI 1640 (Biochrome) with 10% FCS (PAN Biotech). Cells resuspended in PBS/2 mM EDTA were filtered through 40 µm cell strainers (Corning, Durham, NC, USA).
LPL were isolated from different parts of the intestine according to published protocols2,62. Briefly, residual mesenteric fat and Peyer’s Patches were carefully removed. Intestinal tissue was opened longitudinally and washed two to three times in ice-cold PBS with 100 U/ml penicillin/streptomycin (P/S; GIBCO Life Technologies). The epithelial layer and containing intraepithelial leukocytes were removed by two incubation steps in Hank’s balanced salt solution without Ca2+ and Mg2+ (HBSS; Biochrom) supplemented with 5 mM EDTA, 10 mM HEPES and P/S for 20 min at RT with slow rotation (100 rpm) and subsequent vortexing for 15 s. Tissue pieces were washed in PBS P/S, minced and incubated 2–3 times for 20 min at 37 °C in digestion solution containing 4% FCS, 0.25 mg/ml each of collagenase D (Roche), DNaseI (Sigma-Aldrich), and Dispase II (Roche) followed by vigorous vortexing and passage through 40 µm cell strainers. Leukocytes were enriched by density gradient centrifugation at 600 × g for 20 min at RT.
The following reagents were purchased from BioLegend or eBiosciences: anti-mouse CD3 (145-2C11), CD4 (RM4-5), CD5 (53-7.3), CD8a (53-6.7), CD11b (M1/70), CD11c (N418), CD19 (1D3), CD45 (30-F11), CD120a (TNF-RI; 55R-286), CD122 (TM-β1), Eomes (Dan11mag), F4/80 (BM8), GM-CSF (MP1-22E9), IFN-γ (XMG1.2), Ly6C/G/Gr-1 (RB6-8C5), Ly6G/Gr1 (1A8), Ly6C (HK1.4), MCP-1 (2H5), NK1.1 (PK136), T-bet (4B10), Ter119 (TER-119), TNF (MP6-XT22), TRAIL (N2B2), armenian hamster IgG1 (RTK2073), donkey-anti-rabbit IgG (Poly4064), rat IgG1, κ (RTK2071), rat IgG2a, κ (RTK2758), and Zombie viability dye. Anti-mouse CD16/32 (2.4G2; ATCC® HB-197™) was produced in our laboratory. Anti-mouse CD11b (M1/70), GATA-3 (TWAJ), NKp46 (29A14), pSTAT5 pY694 (47/Stat5), RORγt (B2D), and Streptavidin-FITC were purchased from BD Biosciences. Polyclonal rabbit-anti-c-FLIP was purchased from Abcam. Anti-mouse Ly49A (A1), Ly49C/I (REA253), and Eomes (REA116) were purchased from Miltenyi Biotec. Further antibody information is provided in Supplementary Table 1.
Single cell suspensions of spleen, BM as well as LPL were stained with fluorochrome-labeled antibodies for 30 min at 4 °C after blocking Fc receptors with anti-CD16/32. For detection of cytoplasmic antigens, cells were incubated in fixation buffer (BioLegend) for 30 min at 4 °C, permeabilized and stained with the appropriate antibodies in permeabilization wash buffer (BioLegend) for 30 min at 4 °C. For staining of nuclear antigens, cells were permeabilized and fixed using the Foxp3 staining buffer set (eBioscience) according to the manufacturer’s instructions. Peripheral blood leukocytes were stained in whole blood samples for 30 min at RT, followed by erythrocyte lysis and fixation using BD FACSTM lysing solution (BD Biosciences). Samples were measured on a LSR Fortessa and FACSCanto flow cytometer (Becton Dickinson) and analyzed by FlowJo software (FlowJo LLC).
In vitro stimulation of splenic ILC
Splenocytes were isolated from C57BL/6 mice and cultured for 16 h in RPMI (with 10% FCS and 100 U/ml P/S) supplemented with IL-15 (10 ng/ml, Peprotech), with rmIL-15 (10 ng/ml) and pimozide (5 μM, Calbiochem) or were left untreated. Lineage negative (CD3−, CD4−, CD8−, CD19−, Gr1−, Ter119−) CD122+NK1.1+NKp46+ ILC were analyzed by flow cytometry for their expression of c-FLIP and phosphorylation of STAT5.
Detection of apoptotic cells
Apoptotic cells were visualized by flow cytometry by using the FAM-FLICA Caspase 3/7 assay kit from ImmunoChemistry Technologies according to the manufacturer’s protocol. The cell permeable, fluorescent inhibitor probe FAM-DEVD-FMK irreversibly binds to active caspases 3 and 7.
In vitro culture of ILC precursors
BM-derived ILC precursors were enriched by depletion of Ter119−, CD19−, and LyG/Gr1-positive cells using the respective biotinylated antibodies (Ter119, CD19, and Ly6G/Gr1; clones as indicated above) and anti-biotin Dynabeads (Invitrogen) according to the manufacturer’s recommendations. Next, the Ter119/CD19/Gr1-depleted cell suspension was labeled with antibodies against CD3, CD4, CD8, CD122, and NK1.1 and FITC-conjugated streptavidin. Lineage negative (Ter119−, CD19−, Ly6G/Gr1−, CD3−, CD4−, CD8−) CD122+NK1.1− BM ILC precursors were enriched (on average 42%) by fluorescence-activated cell sorting (FACS Vantage DIVA, FACS Aria III, Becton Dickinson). ILC precursors were co-cultured with irradiated (4 Gy) OP9 cells (ATCC® CRL-2749™) in α-MEM medium (GIBCO Life Technologies) containing 10% FCS, 20 ng/ml SCF (Peprotech), 20 ng/ml Flt-3 ligand (Peprotech), 20 ng/ml IL-7 (eBioscience), 20 ng/ml IL-15 (Peprotech), 150 µM 1-thioglycerol (Sigma-Aldrich), 2 mM l-glutamine (GIBCO Life technologies), 1 mM Na-pyruvate (GIBCO Life technologies), 100 U/ml penicillin/streptomycin, and 1 x primocin (Amaxa) for 9 days. After 4 days of co-culture, 50% of medium was replaced. Two days later cells were moved to a fresh OP9 feeder cell layer. At day 9 of co-culture cells were analyzed by flow cytometry. To block TNF-, FASL- or TRAIL-mediated signaling, 10 µg/ml of anti-TNF (MP6-XT22), anti-FASL (3C82; Enzo), or anti-TRAIL (N2B2), respectively, were added to the co-cultures every 2.5 days. Isotype-matched control antibodies were used as controls. Blocking/control reagents were purchased from BioLegend.
Quantitative real-time PCR (RT-qPCR)
FACS-sorted splenic ILC (CD3−NKp46+NK1.1+) were stimulated with IL-15 (50 ng/ml) for 16 h or were left untreated. ILC progenitors were sorted using MoFlo Sorter (Beckman Coulter) from BM extracts. RNA isolation from cell cultures and primary cells was performed using QIAshredder and RNeasy Mini Kit (QIAGEN) according to manufacturer’s protocol. cDNA was synthetized using the cDNA Synthesis Kit (Life technologies) according to manufacturer’s instructions. The cDNA served as a template for the amplification by real-time PCR, using SYBR Green (Roche) in a LightCycler 96 instrument (Roche). Ubiquitin-conjugating enzyme E2D 2A (UCE) was used as reference gene. Primers: UCE fwd: 5′-AAGAGAATCCACAAGGAATTGAATG-3′; UCE rev: 5′-CAACAGGACCTGCTGA ACACTG-3′. CD95 (FAS) fwd: 5′-GCAGACAUGCUGUGGAUCUG-3; CD95 (FAS) rev: 5´-UCGGAGAUGCUAUUAGUACCUUGAG-3. DR5 (TRAIL-R2) fwd: 5′-CCCUGAGAUCUGCCAGUCAU-3´; DR5 (TRAIL-R2) rev: 5′-UGGGGGUACAGGAAGUCAGU-3′. TNF-R1 fwd: 5′-GAAAGUAUGUCCAUUCUAAGAACAA-3′; TNF-R1 rev: 5′-AGUCACUCACCAAGUAGGUUCCUU-3′. c-FLIPL fwd: 5′-GCAGAAGCUCUCCCAGCA-3; c-FLIPL rev: 5′-UUUGUCCAUGAGUUCAACGUG-3′. c-FLIPR fwd: 5′-UCCAGAAGUACACCCAGUCCA-3′; c-FLIPR rev: 5′-CACUGGCUCCAGACUCACC-3′.
Acute colitis was induced by administration of 1.8–2.5% (w/v) dextran sulfate sodium (DSS; MW 36,000–50,000; ICN Biomedicals) ad libitum via the drinking water for 5 consecutive days. Chronic colitis was induced by repeated DSS administration (1.6%) for 5 days interrupted by 14-day periods on normal drinking water. Total body weight and feces samples were monitored. Feces consistency was evaluated to determine the degree of diarrhea. Furthermore, feces samples were analyzed for occult blood to determine the degree of intestinal bleeding. Occult blood was detected using hemoCARE test (Care diagnostic). Disease activity score was calculated by summarizing the scores for weight loss, feces consistency, and bleeding63.
Tissue samples from distal, medial, and proximal colon (0.5–1 cm) were fixed in 4% formalin and embedded in paraffin. 1–2 µm-thick sections were cut, dewaxed, and histochemically stained with hematoxylin & eosin (Merck). Histomorphological changes were evaluated in (HE)-stained tissue sections and images (original magnification ×100) were taken by standard light microscopy using an AxioImager Z1 microscope (Carl Zeiss MicroImaging, Jena, Germany). Histopathological evaluation was performed in a blinded manner using a standardized histologic score ranging from 0 to 664.
Analysis of colonic cytokine production
Samples of ~1 cm in length were isolated from the proximal, medial, and distal part of each colon. Samples were cleaned, opened longitudinally, and weighed. These colonic tissue explants were cultured in 500 µl complete RPMI 1640 supplemented with 2% FCS and 100 U/ml P/S in 24-well flat-bottom plates at 37 °C/5% CO2 for 24 h. Culture supernatants were harvested and subsequently centrifuged at 10,000 × g for 10 min to remove debris. Supernatants were stored at −80 °C. Cytokine levels were measured using the Legendplex Mouse inflammation panel (Biolegend) or IL-22-ELISA (Affimetrix/eBioscience) according to the manufacturer’s instructions. Cytokine levels were normalized to tissue mass and expressed as picogram of cytokine per microgram of tissue. Normalized cytokine data from the three colonic tissue explants per mouse were pooled.
For the flow cytometric analysis of cytokine production, colon samples from 2 to 3 mice were pooled, LPL were enriched and cultured subsequently for 5 h in the presence of 20 ng/ml phorbol myristate acetate (PMA)/1 µg/ml ionomycin. Brefeldin A (BD GolgiPlugTM; BD Biosciences) was added for the last 4 h of culture. Stimulated LPL were washed and incubated with fluorochrome-labeled antibodies for 30 min at 4 °C in the dark. After washing, LPL were fixed using the Fixation buffer for intracellular staining procedures (Biolegend) for 15 min in the dark at RT. Samples were washed with PBS/2 mM EDTA and stored in PBS/0.5% (w/v) BSA/2 mM EDTA containing anti-CD16/32 overnight. Subsequently, cells were washed in 200 µl permeabilization buffer (Biolegend) and incubated with fluorochome-labeled anti-cytokine mAbs or isotype-matched control antibodies for 1 h at 4 °C. After washing cells were resuspended in PBS/2 mM EDTA, measured on a LSR Fortessa (Becton Dickinson) flow cytometer and analyzed by FlowJo software (FlowJo LLC).
C57BL/6 mice were injected i.p. with 50 µg of NK-depleting anti-Asialo GM1 (Affimetrix). Treatment was repeated every third day. A total of four injections were performed. Control animals were treated accordingly with 50 µg polyclonal rabbit control IgG (Sigma-Aldrich).
Experimental results were plotted and analyzed for statistical significance with Prism software 5 or 6 (GraphPad Software Inc.). Statistical significances were determined using two-tailed Mann–Whitney U test, paired and unpaired Student’s t test or two-tailed Wilcoxon matched-pairs signed rank test (*p ≤ 0.05; **p ≤ 0.005; ***p ≤ 0.001; ****p ≤ 0.0001). Exact p values are provided in Source data.
Feces samples were collected and stored at −20 °C until processing for DNA-based 16S rRNA gene sequencing. DNA was extracted using an established phenol–chloroform-based method65. In short, 500 µl of extraction buffer (200 mM Tris (Roth), 20 mM EDTA (Roth), 200 mM NaCl (Roth), pH 8.0), 200 µl of 20% SDS (AppliChem), 500 µl of phenol:chloroform:isoamyl alcohol (PCI) (24:24:1) (Roth) and 100 µl of zirconia/silica beads (0.1 mm diameter) (Roth) were added to each feces sample. Samples were lysed and homogenized twice using a Mini-BeadBeater-96 (BioSpec) for 2 min. After centrifugation and additional extraction with PCI (24:24:1), DNA was precipitated using 500 µl isopropanol (J.T.Baker) and 0.1 volume of 3 M sodium acetate (AppliChem). Samples were incubated at −20 °C overnight and centrifuged at 4 °C at maximum speed for 20 min. The resulting DNA pellet was dried, resuspended in TE buffer (AppliChem) with 100 µg/ml RNase I (Sigma-Aldrich) and column purified (BioBasic Inc.) to remove PCR inhibitors.
16S rRNA gene amplification and sequencing
16S rRNA gene amplification of the V4 region (F515/R806) was performed according to an established protocol previously described40. Briefly, DNA was normalized to 25 ng/µl and used for sequencing PCR with unique 12-base Golary barcodes incorporated via specific primers (obtained from Sigma-Aldrich). Using Q5 polymerase (New England Biolabs), PCR was performed in triplicates for each sample, using PCR conditions of initial denaturation for 30 s at 98 °C, followed by 25 cycles (10 s at 98 °C, 20s at 55 °C, and 20 s at 72 °C). After pooling and normalization to 10 nM, PCR amplicons were sequenced on an Illumina MiSeq platform via 250 bp paired-end sequencing (PE250).
16S rRNA gene analysis
Using Usearch8.1 software package (http://www.drive5.com/usearch/) the resulting reads were assembled, filtered, and clustered. In brief, merging was performed using -fastq_mergepairs –with fastq_maxdiffs 30 and quality controlling was performed with fastq_filter (-fastq_maxee 1), using a minimum read length of 200 bp and a minimum number of sequences per sample = 1000 as thresholds. Reads were clustered into 97% ID OTUs and representative sequences were determined by use of UPARSE algorithm66. Taxonomy classification was performed with the Silva database v12867 and the RDP Classifier executed at 80% bootstrap confidence68. Resulting OTU absolute abundance table and mapping file were used for statistical analyses and data visualization using R statistical programming environment (R Core Team (2016)) package phyloseq69.
Statistics were performed with ‘R’ version 3.3.0 (2016-05-03), (http://www.rproject.org) and the packages ‘phyloseq’69, and ‘ggplot2’70. Non-parametric Mann–Whitney U tests were considered as significant when P values were lower than 0.05 after multiple testing correction (Benjamini–Hochberg false discovery rate correction). Permutational multivariate analysis of variance test (ADONIS) was used to assess the influence of different variables on the sample variability. The ADONIS tests were computed using 999 permutations and a resulting R2 > 0.1 (effect size 10%) and P-values < 0.05 were considered as significant. LDA effect size (LEfSe) method was used to identify bacterial OTUs that explained differences between microbiota compositions41. Only OTUs with Kruskal–Wallis test < 0.05 and LDA scores > 3.0 were considered for analysis.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
16S rRNA gene sequencing data have been deposited in the NCBI (Bioproject Database) under the accession number: PRJNA437582. The source data underlying Figs. 1a–d, 2a–f, 3e–k, 4a–f and i–m, 5a–c, and e–h, 6a–f, 7c and d, 8a–f, i and k and Supplementary Figs. 1, 2, 3a, and e, 4a and e–k are provided as a Source Data file. All other data that support the findings of this study are available from the corresponding author on reasonable request.
Spits, H. et al. Innate lymphoid cells—a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145–149 (2013).
Klose, C. S. N. et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340–356 (2014).
Long, E. O., Kim, H. S., Liu, D., Peterson, M. E. & Rajagopalan, S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 31, 227–258 (2013).
Moro, K. et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463, 540–544 (2010).
Satoh-Takayama, N. et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958–970 (2008).
Sonnenberg, G. F., Fouser, L. A. & Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12, 383–390 (2011).
Lindemans, C. A. et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528, 560–564 (2015).
Sawa, S. et al. RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat. Immunol. 12, 320–326 (2011).
Rankin, L. C. et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat. Immunol. 17, 179–186 (2016).
Song, C. et al. Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J. Exp. Med. 212, 1869–1882 (2015).
Vély, F. et al. Evidence of innate lymphoid cell redundancy in humans. Nat. Immunol. 17, 1291–1299 (2016).
Klose, C. S. & Diefenbach, A. Transcription factors controlling innate lymphoid cell fate decisions. Curr. Top. Microbiol. Immunol. 381, 215–255 (2014).
Rochman, Y., Spolski, R. & Leonard, W. J. New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 9, 480–490 (2009).
Satoh-Takayama, N. et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J. Exp. Med. 207, 273–280 (2010).
Huntington, N. D. et al. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat. Immunol. 8, 856–863 (2007).
Link, A. et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol. 8, 1255–1265 (2007).
Gil-Cruz, C. et al. Fibroblastic reticular cells regulate intestinal inflammation via IL-15-mediated control of group 1 ILCs. Nat. Immunol. 17, 1388–1396 (2016).
Shalapour, S. et al. Interleukin-7 links T lymphocyte and intestinal epithelial cell homeostasis. PLoS One 7, e31939 (2012).
Narni-Mancinelli, E. et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc. Natl Acad. Sci. USA 108, 18324–18329 (2011).
Irmler, M. et al. Inhibition of death receptor signals by cellular FLIP. Nature 388, 190–195 (1997).
Chau, H. et al. Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J. Exp. Med. 202, 405–413 (2005).
Panayotova-Dimitrova, D. et al. cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. Cell Rep. 5, 397–408 (2013).
Zhang, N. & He, Y.-W. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J. Exp. Med. 202, 395–404 (2005).
Ueffing, N., Schuster, M., Keil, E., Schulze-Osthoff, K. & Schmitz, I. Up-regulation of c-FLIP short by NFAT contributes to apoptosis resistance of short-term activated T cells. Blood 112, 690–698 (2008).
Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771–780 (2000).
Fuchs, A. et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity 38, 769–781 (2013).
Ueffing, N. et al. Mutational analyses of c-FLIPR, the only murine short FLIP isoform, reveal requirements for DISC recruitment. Cell Death Differ. 15, 773–782 (2008).
Carson, W. E. et al. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J. Clin. Invest. 99, 937–943 (1997).
Ebbo, M., Crinier, A., Vély, F. & Vivier, E. Innate lymphoid cells: major players in inflammatory diseases. Nat. Rev. Immunol. 17, 665–678 (2017).
Mirandola, P. et al. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity. Blood 104, 2418–2424 (2004).
Lodolce, J. P. et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669–676 (1998).
Robinette, M. L. et al. IL-15 sustains IL-7R-independent ILC2 and ILC3 development. Nat. Commun. 8, 14601 (2017).
Wirtz, S., Neufert, C., Weigmann, B. & Neurath, M. F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541–546 (2007).
Kaser, A., Zeissig, S. & Blumberg, R. S. Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573–621 (2010).
Eftychi, C. et al. Temporally distinct functions of the cytokines IL-12 and IL-23 drive chronic colon inflammation in response to intestinal barrier impairment. Immunity 51, 367–380.e4 (2019).
Egea, L. et al. GM-CSF produced by nonhematopoietic cells is required for early epithelial cell proliferation and repair of injured colonic mucosa. J. Immunol. 190, 1702–1713 (2013).
Blander, J. M., Longman, R. S., Iliev, I. D., Sonnenberg, G. F. & Artis, D. Regulation of inflammation by microbiota interactions with the host. Nat. Immunol. 18, 851–860 (2017).
Levy, M., Kolodziejczyk, A. A., Thaiss, C. A. & Elinav, E. Dysbiosis and the immune system. Nat. Rev. Immunol. 17, 219–232 (2017).
Roy, U. et al. Distinct microbial communities trigger colitis development upon intestinal barrier damage via innate or adaptive immune cells. Cell Rep. 21, 994–1008 (2017).
Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4516–4522 (2011).
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
Zackular, J. P. et al. The gut microbiome modulates colon tumorigenesis. MBio 4, e00692–13 (2013).
Sonnenberg, G. F. et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336, 1321–1325 (2012).
Pikovskaya, O. et al. Cutting edge: eomesodermin is sufficient to direct Type 1 Innate lymphocyte development into the conventional NK lineage. J. Immunol. 196, 1449–1454 (2016).
Kwong, B. et al. T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation. Nat. Immunol. 18, 1117–1127 (2017).
Weizman, O. E. et al. ILC1 confer early host protection at initial sites of viral infection. Cell 171, 795–808.e12 (2017).
Vonarbourg, C. & Diefenbach, A. Multifaceted roles of interleukin-7 signaling for the development and function of innate lymphoid cells. Semin. Immunol. 24, 165–174 (2012).
Marçais, A. et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15, 749–757 (2014).
Hall, L. J. et al. Natural killer cells protect mice from DSS-induced colitis by regulating neutrophil function via the NKG2A receptor. Mucosal Immunol. 6, 1016–1026 (2013).
Rapaport, A. S. et al. The inhibitory receptor NKG2A sustains virus-specific CD8+ T cells in response to a lethal poxvirus infection. Immunity 43, 1112–1124 (2015).
Hall, L. J. et al. Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis. Dig. Dis. Sci. 56, 79–89 (2011).
Shaul, M. E. & Fridlender, Z. G. Neutrophils as active regulators of the immune system in the tumor microenvironment. J. Leukoc. Biol. 102, 343–349 (2017).
Bronte, V. et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7, 12150 (2016).
Katoh, H. et al. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 24, 631–644 (2013).
Neurath, M. F. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat. Immunol. 20, 970–979 (2019).
Cui, Y. et al. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell Biol. 24, 8037–8047 (2004).
Reinhardt, R. L., Liang, H.-E. & Locksley, R. M. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 10, 385–393 (2009).
Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869–877 (1992).
Peschon, J. J. et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med 180, 1955–1960 (1994).
McCaughtry, T. M. et al. Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J. Exp. Med 209, 2263–2276 (2012).
Zhu, Y. et al. T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. J. Immunol. 185, 3174–3183 (2010).
Sanos, S. L. & Diefenbach, A. Isolation of NK cells and NK-like cells from the intestinal lamina propria. Methods Mol. Biol. 612, 505–517 (2010).
Bank, U. et al. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)–a novel approach for the treatment of inflammatory bowel disease. Int Immunopharmacol. 6, 1925–1934 (2006).
Erben, U. et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J. Clin. Exp. Pathol. 7, 4557–4576 (2014).
Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480–484 (2009).
Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996–998 (2013).
Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41, D590–D596 (2013).
Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ. Microbiol 73, 5261–5267 (2007).
McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8, e61217 (2013).
Wickham, H. ggplot2: elegant graphics for data analysis (Springer, 2016).
We thank E. Denks, J. Giese, C. Kozowsky, J. Nichelmann, S. Schumann, and M. Berger for excellent technical assistance. We are grateful to Dr. Y.-W. He for providing c-FLIPfl/fl mice. This work was supported by the Deutsche Forschungsgemeinschaft Sonderforschungsbereich SFB854 (project A22) and DFG priority program 1937 (project SCHU 2326/2-1).
The authors declare competing financial interests. The E.V. laboratory is supported by the European Research Council (ERC) under the “European Union’s Horizon 2020 research and innovation program (Grant agreement no. 694502)”, Agence Nationale de la Recherche, Innate Pharma, MSDAvenir, Ligue Nationale contre le Cancer (Equipe labelisée “La Ligue”) and Marseille-Immunopole. E.V. is cofounder, shareholder, and employee of Innate Pharma.
Peer review information Nature Communications thanks Shigeo Koyasu and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bank, U., Deiser, K., Plaza-Sirvent, C. et al. c-FLIP is crucial for IL-7/IL-15-dependent NKp46+ ILC development and protection from intestinal inflammation in mice. Nat Commun 11, 1056 (2020). https://doi.org/10.1038/s41467-020-14782-3
CCR8 Signaling via CCL1 Regulates Responses of Intestinal IFN-γ Producing Innate Lymphoid CelIs and Protects From Experimental Colitis
Frontiers in Immunology (2021)
Frontiers in Immunology (2020)
Life Sciences (2020)